Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention

被引:237
作者
Chhatriwalla, Adnan K. [2 ,3 ]
Amin, Amit P. [4 ]
Kennedy, Kevin F. [1 ]
House, John A. [1 ]
Cohen, David J. [2 ,3 ]
Rao, Sunil V. [5 ]
Messenger, John C. [6 ,7 ]
Marso, Steven P. [2 ,3 ]
机构
[1] St Lukes Mid Amer Heart Inst, Dept Biostat, Kansas City, MO 64111 USA
[2] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA
[3] Univ Missouri Kansas City, Sch Med, Dept Internal Med, Div Cardiol, Kansas City, MO USA
[4] Washington Univ, Sch Med, Dept Internal Med, Div Cardiol, St Louis, MO 63110 USA
[5] Duke Clin Res Inst, Dept Internal Med, Div Cardiol, Durham, NC USA
[6] Univ Colorado Denver, Dept Internal Med, Div Cardiol, Denver, CO USA
[7] Denver VA Med Ctr, Denver, CO USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 309卷 / 10期
关键词
GLYCOPROTEIN IIB/IIIA INHIBITION; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; ANTITHROMBOTIC THERAPY; ECONOMIC-EVALUATION; PROGNOSTIC IMPACT; PROPENSITY SCORE; ISCHEMIC EVENTS; RISK; BIVALIRUDIN;
D O I
10.1001/jama.2013.1556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Bleeding is the most common complication after percutaneous coronary intervention (PCI) and is associated with increased morbidity and health care costs. The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear. Objectives To describe the association between bleeding events and in-hospital mortality after PCI and to estimate the adjusted population attributable risk (estimated as the proportion of mortality risk associated with bleeding events), risk difference, and number needed to harm (NNH) for bleeding-related in-hospital mortality after PCI. Design, Setting, and Patients Data from 3 386 688 procedures in the CathPCI Registry performed in the United States between 2004 and 2011 were analyzed. The population attributable risk was calculated after adjustment for baseline demographic, clinical, and procedural variables. To calculate the NNH for bleeding-related mortality, a propensity-matched analysis was performed. Main Outcome Measures In-hospital mortality. Results There were 57 246 bleeding events (1.7%) and 22 165 in-hospital deaths (0.65%) in 3 386 688 PCI procedures. The adjusted population attributable risk for mortality related to major bleeding was 12.1% (95% CI, 11.4%-12.7%) in the entire CathPCI cohort. The propensity-matched population consisted of 56 078 procedures with a major bleeding event and 224 312 controls. In this matched cohort, major bleeding was associated with increased in-hospital mortality (5.26% vs 1.87%; risk difference, 3.39% [95% CI, 3.20%-3.59%]; NNH=29 [95% CI, 28-31]; P < .001). The association between major bleeding and in-hospital mortality was observed in all strata of preprocedural bleeding risk (low: 1.62% vs 0.17%; risk difference, 1.45% [95% CI, 1.13%-1.77%], NNH=69 [95% CI, 57-88], P < .001; intermediate: 3.27% vs 0.71%; risk difference, 2.56% [95% CI, 2.33%-2.79%], NNH=39 [95% CI, 36-43], P < .001; and high: 8.16% vs 3.45%; risk difference, 4.71% [95% CI, 4.35%-5.07%], NNH=21 [95% CI, 20-23], P < .001). Although both access-site and non-access-site bleeding were associated with increased in-hospital mortality (2.73% vs 1.87%; risk difference, 0.86% [95% CI, 0.66%-1.05%], NNH=117 [95% CI, 95-151], P < .001; and 8.25% vs 1.87%; risk difference, 6.39% [95% CI, 6.04%-6.73%], NNH=16 [95% CI, 15-17], P < .001, respectively), the NNH was lower for nonaccess bleeding. Conclusions and Relevance In a large registry of patients undergoing PCI, post-procedural bleeding events were associated with increased risk of in-hospital mortality, with an estimated 12.1% of deaths related to bleeding complications. JAMA. 2013;309(10):1022-1029 www.jama.com
引用
收藏
页码:1022 / 1029
页数:8
相关论文
共 33 条
[11]   Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial [J].
Cohen, DJ ;
Lincoff, AM ;
Lavelle, TA ;
Chen, HL ;
Bakhai, A ;
Berezin, RH ;
Jackman, D ;
Sarembock, IJ ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1792-1800
[12]   Adverse impact of bleeding on prognosis in patients with acute coronary syndromes [J].
Eikelboom, John W. ;
Mehta, Shamir R. ;
Anand, Sonia S. ;
Xie, Changchun ;
Fox, Keith A. A. ;
Yusuf, Salim .
CIRCULATION, 2006, 114 (08) :774-782
[13]   Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials [J].
Jolly, Sanjit S. ;
Amlani, Shoaib ;
Hamon, Martial ;
Yusuf, Salim ;
Mehta, Shamir R. .
AMERICAN HEART JOURNAL, 2009, 157 (01) :132-140
[14]   Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions [J].
Kinnaird, TD ;
Stabile, E ;
Mintz, GS ;
Lee, CW ;
Canos, DA ;
Gevorkian, N ;
Pinnow, EE ;
Kent, KM ;
Pichard, AD ;
Satler, LF ;
Weissman, NJ ;
Lindsay, J ;
Fuchs, S .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (08) :930-935
[15]   Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry [J].
Lindsey, Jason B. ;
Marso, Steven P. ;
Pencina, Michael ;
Stolker, Joshua M. ;
Kennedy, Kevin F. ;
Rihal, Charanjit ;
Barsness, Greg ;
Piana, Robert N. ;
Goldberg, Steven L. ;
Cutlip, Donald E. ;
Kleiman, Neal S. ;
Cohen, David J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (11) :1074-1082
[16]   Advanced Age, Antithrombotic Strategy, and Bleeding in Non-ST-Segment Elevation Acute Coronary Syndromes [J].
Lopes, Renato D. ;
Alexander, Karen P. ;
Manoukian, Steven V. ;
Bertrand, Michel E. ;
Feit, Frederick ;
White, Harvey D. ;
Pollack, Charles V., Jr. ;
Hoekstra, James ;
Gersh, Bernard J. ;
Stone, Gregg W. ;
Ohman, Magnus .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (12) :1021-1030
[17]   Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes - An analysis from the ACUITY trial [J].
Manoukian, Steven V. ;
Feit, Frederick ;
Mehran, Roxana ;
Voeltz, Michele D. ;
Ebrahimi, Ramin ;
Hamon, Martial ;
Dangas, George D. ;
Lincoff, A. Michael ;
White, Harvey D. ;
Moses, Jefrey W. ;
King, Spencer B., III ;
Ohman, E. Magnus ;
Stone, Gregg W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (12) :1362-1368
[18]   Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention [J].
Marso, Steven P. ;
Amin, Amit P. ;
House, John A. ;
Kennedy, Kevin F. ;
Spertus, John A. ;
Rao, Sunil V. ;
Cohen, David J. ;
Messenger, John C. ;
Rumsfeld, John S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (21) :2156-2164
[19]   New paradigms of care for STEMI focusing on mortality and attributable death analysis: what do device and drug trials teach us? [J].
Mehran, Roxana ;
Stone, Gregg W. .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0C) :C4-C8
[20]   Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial [J].
Mehran, Roxana ;
Pocock, Stuart J. ;
Stone, Gregg W. ;
Clayton, Tim C. ;
Dangas, George D. ;
Feit, Frederick ;
Manoukian, Steven V. ;
Nikolsky, Eugenia ;
Lansky, Alexandra J. ;
Kirtane, Ajay ;
White, Harvey D. ;
Colombo, Antonio ;
Ware, James H. ;
Moses, Jeffrey W. ;
Ohman, E. Magnus .
EUROPEAN HEART JOURNAL, 2009, 30 (12) :1457-1466